Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer
Kluth, Martina, Ahrary, Ramin, Hube-Magg, Claudia, Ahmed, Malik, Volta, Heinke, Schwemin, Catina, Steurer, Stefan, Wittmer, Corinna, Wilczak, Waldemar, Burandt, Eike, Krech, Till, Adam, Meike, Michl, Uwe, Heinzer, Hans, Salomon, Georg, Graefen, Markus, Koop, Christina, Minner, Sarah, Simon, Ronald, Sauter, Guido, Schlomm, Thorsten
Published in Oncotarget (29.09.2015)
Published in Oncotarget (29.09.2015)
Get full text
Journal Article
Correction: Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancer
Kluth, Martina, Ahrary, Ramin, Hube-Magg, Claudia, Ahmed, Malik, Volta, Heinke, Schwemin, Catina, Steurer, Stefan, Wittmer, Corinna, Wilczak, Waldemar, Burandt, Eike, Krech, Till, Adam, Meike, Michl, Uwe, Heinzer, Hans, Salomon, Georg, Graefen, Markus, Koop, Christina, Minner, Sarah, Simon, Ronald, Sauter, Guido, Schlomm, Thorsten
Published in Oncotarget (10.01.2017)
Published in Oncotarget (10.01.2017)
Get full text
Journal Article
Deletion of 3p13 is a late event linked to progression of TMPRSS2 : ERG fusion prostate cancer
Kluth, Martina, Volta, Heinke, Hussein, Mohammad, Taskin, Billurvan, Frogh, Sohall, Möller-Koop, Christina, Büscheck, Franziska, Jacobsen, Frank, Tsourlakis, Maria Christina, Lübke, Andreas M, Hinsch, Andrea, Clauditz, Till, Graefen, Markus, Heinzer, Hans, Huland, Hartwig, Minner, Sarah, Sauter, Guido, Wilczak, Waldemar, Schlomm, Thorsten, Simon, Ronald
Published in Cancer management and research (01.01.2018)
Published in Cancer management and research (01.01.2018)
Get full text
Journal Article